Logo image of CPSI

COMPUTER PROGRAMS & SYSTEMS (CPSI) Stock Fundamental Analysis

NASDAQ:CPSI - Nasdaq - US2053061030 - Common Stock - Currency: USD

9.19  +0.33 (+3.72%)

After market: 9.19 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CPSI. CPSI was compared to 35 industry peers in the Health Care Technology industry. There are concerns on the financial health of CPSI while its profitability can be described as average. CPSI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CPSI had positive earnings in the past year.
In the past year CPSI had a positive cash flow from operations.
CPSI had positive earnings in 4 of the past 5 years.
CPSI had a positive operating cash flow in 4 of the past 5 years.
CPSI Yearly Net Income VS EBIT VS OCF VS FCFCPSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M 40M

1.2 Ratios

CPSI has a better Return On Assets (-0.18%) than 85.00% of its industry peers.
CPSI's Return On Equity of -0.33% is amongst the best of the industry. CPSI outperforms 85.00% of its industry peers.
With an excellent Return On Invested Capital value of 0.46%, CPSI belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CPSI is in line with the industry average of 6.74%.
The 3 year average ROIC (5.91%) for CPSI is well above the current ROIC(0.46%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.18%
ROE -0.33%
ROIC 0.46%
ROA(3y)4.18%
ROA(5y)4.71%
ROE(3y)7.24%
ROE(5y)8.61%
ROIC(3y)5.91%
ROIC(5y)6.38%
CPSI Yearly ROA, ROE, ROICCPSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20

1.3 Margins

In the last couple of years the Profit Margin of CPSI has declined.
CPSI has a Operating Margin of 0.61%. This is amongst the best in the industry. CPSI outperforms 82.50% of its industry peers.
CPSI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 47.08%, CPSI is in line with its industry, outperforming 42.50% of the companies in the same industry.
CPSI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.61%
PM (TTM) N/A
GM 47.08%
OM growth 3Y-6.39%
OM growth 5Y-2.51%
PM growth 3Y-12.68%
PM growth 5YN/A
GM growth 3Y-3.42%
GM growth 5Y-2.33%
CPSI Yearly Profit, Operating, Gross MarginsCPSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CPSI is destroying value.
There is no outstanding debt for CPSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CPSI Yearly Shares OutstandingCPSI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M
CPSI Yearly Total Debt VS Total AssetsCPSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.43, we must say that CPSI is in the distress zone and has some risk of bankruptcy.
CPSI has a Altman-Z score of 1.43. This is comparable to the rest of the industry: CPSI outperforms 60.00% of its industry peers.
CPSI has a Debt/Equity ratio of 0.61. This is a neutral value indicating CPSI is somewhat dependend on debt financing.
CPSI's Debt to Equity ratio of 0.61 is on the low side compared to the rest of the industry. CPSI is outperformed by 67.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 1.43
ROIC/WACC0.05
WACC9.37%
CPSI Yearly LT Debt VS Equity VS FCFCPSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.44 indicates that CPSI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.44, CPSI is in line with its industry, outperforming 47.50% of the companies in the same industry.
A Quick Ratio of 1.42 indicates that CPSI should not have too much problems paying its short term obligations.
CPSI's Quick ratio of 1.42 is in line compared to the rest of the industry. CPSI outperforms 47.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.42
CPSI Yearly Current Assets VS Current LiabilitesCPSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CPSI have decreased strongly by -23.60% in the last year.
Measured over the past 5 years, CPSI shows a small growth in Earnings Per Share. The EPS has been growing by 7.71% on average per year.
Looking at the last year, CPSI shows a small growth in Revenue. The Revenue has grown by 6.10% in the last year.
CPSI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.36% yearly.
EPS 1Y (TTM)-23.6%
EPS 3Y0.52%
EPS 5Y7.71%
EPS Q2Q%-21.05%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y5.95%
Revenue growth 5Y3.36%
Sales Q2Q%-0.14%

3.2 Future

CPSI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.06% yearly.
The Revenue is expected to grow by 3.60% on average over the next years.
EPS Next Y-26.07%
EPS Next 2Y-24.81%
EPS Next 3Y-10.06%
EPS Next 5YN/A
Revenue Next Year3.96%
Revenue Next 2Y2.41%
Revenue Next 3Y3.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CPSI Yearly Revenue VS EstimatesCPSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CPSI Yearly EPS VS EstimatesCPSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.50, the valuation of CPSI can be described as very cheap.
100.00% of the companies in the same industry are more expensive than CPSI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.48, CPSI is valued rather cheaply.
The Price/Forward Earnings ratio is 6.30, which indicates a rather cheap valuation of CPSI.
Based on the Price/Forward Earnings ratio, CPSI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CPSI to the average of the S&P500 Index (34.04), we can say CPSI is valued rather cheaply.
Industry RankSector Rank
PE 4.5
Fwd PE 6.3
CPSI Price Earnings VS Forward Price EarningsCPSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CPSI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CPSI is cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.06
CPSI Per share dataCPSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CPSI has a very decent profitability rating, which may justify a higher PE ratio.
CPSI's earnings are expected to decrease with -10.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.58
EPS Next 2Y-24.81%
EPS Next 3Y-10.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CPSI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMPUTER PROGRAMS & SYSTEMS

NASDAQ:CPSI (3/1/2024, 8:08:21 PM)

After market: 9.19 0 (0%)

9.19

+0.33 (+3.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-29 2024-02-29/amc
Earnings (Next)05-07 2024-05-07/amc
Inst Owners55.03%
Inst Owner Change-1.09%
Ins Owners6.84%
Ins Owner Change0%
Market Cap133.71M
Analysts76
Price Target16.83 (83.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.87%
Min EPS beat(2)-32.77%
Max EPS beat(2)5.04%
EPS beat(4)2
Avg EPS beat(4)-11.07%
Min EPS beat(4)-32.77%
Max EPS beat(4)5.04%
EPS beat(8)4
Avg EPS beat(8)-3.79%
EPS beat(12)6
Avg EPS beat(12)-1.38%
EPS beat(16)10
Avg EPS beat(16)1.69%
Revenue beat(2)0
Avg Revenue beat(2)-4.16%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)-3.61%
Revenue beat(4)0
Avg Revenue beat(4)-2.26%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)-0.11%
Revenue beat(8)3
Avg Revenue beat(8)-0.12%
Revenue beat(12)4
Avg Revenue beat(12)-0.91%
Revenue beat(16)5
Avg Revenue beat(16)-0.72%
PT rev (1m)-2.94%
PT rev (3m)-11.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE 4.5
Fwd PE 6.3
P/S 0.4
P/FCF N/A
P/OCF 8.63
P/B 0.59
P/tB N/A
EV/EBITDA 10.06
EPS(TTM)2.04
EY22.2%
EPS(NY)1.46
Fwd EY15.87%
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)1.06
OCFY11.58%
SpS23.15
BVpS15.67
TBVpS-6.87
PEG (NY)N/A
PEG (5Y)0.58
Profitability
Industry RankSector Rank
ROA -0.18%
ROE -0.33%
ROCE 0.55%
ROIC 0.46%
ROICexc 0.46%
ROICexgc 3.81%
OM 0.61%
PM (TTM) N/A
GM 47.08%
FCFM N/A
ROA(3y)4.18%
ROA(5y)4.71%
ROE(3y)7.24%
ROE(5y)8.61%
ROIC(3y)5.91%
ROIC(5y)6.38%
ROICexc(3y)6.11%
ROICexc(5y)6.56%
ROICexgc(3y)41.93%
ROICexgc(5y)39.76%
ROCE(3y)7.04%
ROCE(5y)7.6%
ROICexcg growth 3Y2.33%
ROICexcg growth 5Y-4.44%
ROICexc growth 3Y-9.29%
ROICexc growth 5Y-5.39%
OM growth 3Y-6.39%
OM growth 5Y-2.51%
PM growth 3Y-12.68%
PM growth 5YN/A
GM growth 3Y-3.42%
GM growth 5Y-2.33%
F-Score4
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA 5.09
Cap/Depr 91.14%
Cap/Sales 6.81%
Interest Coverage 0.24
Cash Conversion 56.89%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.42
Altman-Z 1.43
F-Score4
WACC9.37%
ROIC/WACC0.05
Cap/Depr(3y)64.65%
Cap/Depr(5y)43.22%
Cap/Sales(3y)4.04%
Cap/Sales(5y)2.62%
Profit Quality(3y)199.76%
Profit Quality(5y)189.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.6%
EPS 3Y0.52%
EPS 5Y7.71%
EPS Q2Q%-21.05%
EPS Next Y-26.07%
EPS Next 2Y-24.81%
EPS Next 3Y-10.06%
EPS Next 5YN/A
Revenue 1Y (TTM)6.1%
Revenue growth 3Y5.95%
Revenue growth 5Y3.36%
Sales Q2Q%-0.14%
Revenue Next Year3.96%
Revenue Next 2Y2.41%
Revenue Next 3Y3.6%
Revenue Next 5YN/A
EBIT growth 1Y-92.03%
EBIT growth 3Y-0.82%
EBIT growth 5Y0.77%
EBIT Next Year-14.21%
EBIT Next 3Y0.16%
EBIT Next 5YN/A
FCF growth 1Y-117.67%
FCF growth 3Y-32.25%
FCF growth 5Y-10.7%
OCF growth 1Y-69.41%
OCF growth 3Y-9.44%
OCF growth 5Y6.49%